Frontal Fibrosing Alopecia (FFA) London 2026: The Doctor-Led Diagnostic and Treatment Pathway
By the medical team at The London PRP Clinic by The Wellness. Last reviewed April 2026. GMC-registered doctors. Marylebone (2 minutes from Baker Street).
At a glance
Frontal fibrosing alopecia (FFA) is a scarring (cicatricial) form of alopecia primarily affecting postmenopausal women, characterised by progressive hairline recession and eyebrow loss caused by autoimmune-driven destruction of hair follicles. Since first described in 1994, the incidence of FFA has risen rapidly, and it is now considered the most common form of primary cicatricial alopecia in the UK. Critically, FFA is a permanent scarring process where untreated active disease destroys hair follicles permanently. Early diagnosis and aggressive treatment can halt progression and preserve the hair follicles that remain. At The London PRP Clinic by The Wellness, the FFA Initial Consultation Package costs £495 including comprehensive trichoscopic assessment, focused autoimmune blood panel, structured diagnosis, and treatment planning. Personalised treatment combines topical and oral 5-alpha reductase inhibitors, topical and intralesional steroids, hydroxychloroquine where appropriate (through specialist dermatology referral), supportive regenerative therapy, integrated menopausal hormonal assessment, and where appropriate, referral for scalp biopsy to confirm diagnosis. Pricing aligns with London's leading specialist clinics including the London Skin and Hair Clinic in Holborn, Hair GP, Dr Nicola Clayton consultations at the Medical Chambers Kensington, Dr Sharon Belmo at 152 Harley Street (Afro-textured hair specialist), the Thomas Clinic Harley Street, the London Dermatology Centre, the London Hair Loss Clinic Harley Street, and Imperial College Healthcare NHS Trust specialist hair clinic at Charing Cross Hospital.
The reason FFA matters so much in London 2026 is that the condition is rising rapidly in incidence, is being missed by general practitioners and routine dermatology practice for years before correct diagnosis, and the time-to-treatment matters profoundly because every untreated month of active disease means more follicles lost permanently. The patient who has been told her receding hairline is "ageing" or "traction from hair styling" or "general female pattern hair loss" when she actually has FFA loses follicles that could have been saved with timely intervention. The doctor-led integrated pathway at The London PRP Clinic by The Wellness combines specialist trichoscopic diagnostic capability, structured autoimmune workup, multidisciplinary specialist referral pathway, and integration with The Wellness women's health services for menopausal hormonal management, delivering the comprehensive FFA pathway that this serious condition requires.
Message us on WhatsApp for fastest response
Email: team@thewellnesslondon.com
Phone: 020 3951 3429
What is frontal fibrosing alopecia and how is it different from other hair loss?
Frontal fibrosing alopecia is a primary cicatricial (scarring) alopecia, classified as a clinical variant of lichen planopilaris (LPP). It was first described in 1994 by Australian dermatologist Steven Kossard. The published clinical literature including the British Association of Dermatologists 2024 guidance, the SOFFIA international expert alliance 2024 consensus statement (Journal of the European Academy of Dermatology and Venereology 2026), the National Library of Medicine reviews, and the British Hair and Nail Society guidance documents recognise FFA as the most common form of primary cicatricial alopecia in the UK and globally.
The condition is characterised by progressive recession of the frontal hairline, often beginning at the temples and progressing posteriorly, with associated loss of eyebrows in approximately 80% of patients, occasional loss of eyelashes, body hair, and sideburns, perifollicular inflammation at the active margin (sometimes producing itching, burning, or pain), and sometimes facial papules.
The published epidemiology indicates FFA affects predominantly postmenopausal women aged 55-63, although younger women, premenopausal women, and rare male cases occur. The disease is increasing in incidence rapidly across the UK and globally. The aetiology remains incompletely understood but the consensus implicates autoimmune mechanisms (T-cell-mediated attack on follicles), hormonal changes (the postmenopausal predominance and association with hormone replacement therapy), and possibly environmental factors (debate continues regarding sunscreen ingredients and cosmetic products).
How FFA differs from female pattern hair loss. Female pattern hair loss is genetic and androgen-driven, with diffuse thinning across the crown and a preserved frontal hairline. FFA is autoimmune and scarring, with progressive frontal hairline recession, perifollicular inflammation, and eyebrow loss. The treatments are completely different. The diagnostic distinction is critical and is established at trichoscopic examination plus medical history. FFA can be missed for years if treated as routine female pattern hair loss.
How FFA differs from traction alopecia. Traction alopecia results from repeated tension from tight hairstyles, hair extensions, weaves, and chemical processing. The pattern can mimic FFA. The trichoscopic examination distinguishes the two: FFA shows perifollicular inflammation and absent vellus hair at the affected margin, while traction alopecia shows preserved follicles with mechanical damage pattern.
How FFA differs from androgenetic alopecia. Androgenetic alopecia preserves the frontal hairline in women and shows characteristic miniaturisation patterns on trichoscopy. FFA destroys frontal follicles with scarring.
How FFA differs from alopecia areata. Alopecia areata is non-scarring autoimmune hair loss with characteristic exclamation mark hairs, yellow dots, and black dots on trichoscopy. FFA is scarring with permanent follicle destruction. The two can occasionally co-exist.
How FFA differs from lichen planopilaris (LPP) generally. FFA is a clinical variant of LPP affecting specifically the frontal hairline and eyebrows. Other LPP variants affect different scalp distributions. The treatment approaches are similar.
What is the diagnostic process for FFA at The London PRP Clinic by The Wellness?
The structured diagnostic pathway covers six stages.
Stage one: detailed medical history. Your GMC-registered doctor reviews timeline of hair loss, menopausal status and timeline, hormone replacement therapy use, autoimmune family history, personal history of autoimmune conditions, environmental and cosmetic product use, hair styling practices, sunscreen use patterns, family history of FFA or LPP, and associated symptoms (itching, burning, pain along the hairline).
Stage two: focused examination. Examination of the scalp under good lighting identifies the characteristic pattern: hairline recession with band of smooth pale scarring, eyebrow loss, perifollicular inflammation at the active margin. The Olsen scale and other validated severity measures quantify disease extent.
Stage three: trichoscopy. Magnified scalp examination is the first-line diagnostic tool for FFA and is central to distinguishing FFA from conditions it resembles. Characteristic FFA features include perifollicular erythema, scale, single hairs (loss of vellus hairs at the hairline margin), patchy hair loss, absence of vellus hair, and pinpoint dilated capillaries. Trichoscopy alone often clarifies the diagnosis where examination is ambiguous.
Stage four: comprehensive blood panel where indicated. The FFA Panel covers full blood count, TSH plus free T4 plus anti-TPO antibodies (autoimmune thyroid disease frequently associates with FFA), ANA and ENA panel where autoimmune cause suspected, vitamin D, ferritin, iron studies, oestradiol with FSH and LH (menopausal status confirmation and HRT planning), DHEA-S and free androgen index (rule out androgen contribution), inflammatory markers (CRP, ESR), and HbA1c.
Stage five: scalp biopsy where diagnosis uncertain. A 4mm punch biopsy of the affected margin provides definitive diagnosis through dermatopathology examination. Biopsy is recommended where clinical and trichoscopic features are ambiguous, where the diagnosis would change treatment significantly, or where mimicking conditions need to be excluded. We refer to specialist dermatopathology partners where biopsy is required.
Stage six: structured diagnosis and treatment planning. With the complete diagnostic picture, your doctor explains the diagnosis, the disease activity (active progression versus stable), the prognosis, and the personalised treatment plan. Active disease requires aggressive intervention; stable disease may require observation only or supportive care.
WhatsApp the team to discuss your hairline recession
What treatments work for frontal fibrosing alopecia?
The evidence-based treatment for FFA is informed by the SOFFIA 2024 international consensus, the British Association of Dermatologists 2024 guidance, and the published systematic reviews. Treatment aims to halt disease progression and preserve remaining follicles; reversing follicles already lost is not possible because the scarring process destroys the infrastructure permanently.
Topical 5-alpha reductase inhibitors. Topical finasteride (compounded 0.1-0.25% solution) applied to the affected hairline daily. Mechanism: blocks DHT production locally to reduce the hormonal contribution to disease activity. Available through structured prescribing pathway.
Oral 5-alpha reductase inhibitors. Oral finasteride 1mg or oral dutasteride 0.5mg daily are evidence-supported for FFA. The 2024 systematic reviews indicate disease stabilisation in 60-70% of treated patients. Available through structured prescribing pathway with informed consent regarding off-label use.
Topical corticosteroids. Potent topical steroids (clobetasol 0.05%, betamethasone) applied to the active margin reduce perifollicular inflammation. Used for short-term flare management.
Topical calcineurin inhibitors. Tacrolimus 0.1% ointment as steroid-sparing alternative for long-term management.
Intralesional corticosteroid injection. Triamcinolone acetonide injected directly along the hairline reduces inflammation and slows progression. Typically delivered every 4-6 weeks during active disease. We refer to specialist dermatology colleagues for intralesional steroid procedures where indicated.
Systemic immunomodulators. Hydroxychloroquine 200-400mg daily is evidence-supported as systemic treatment for FFA. Requires baseline ophthalmology review and ongoing monitoring. Methotrexate, ciclosporin, and other immunosuppressants are second-line. We refer to specialist consultant dermatology for systemic immunomodulator initiation and monitoring.
Hormone replacement therapy considerations. Some women have onset of FFA following HRT initiation; others have stabilisation with HRT. The relationship is complex and requires individualised assessment. Where HRT is appropriate clinically (perimenopausal symptoms, bone health, cardiovascular protection), structured HRT through The Wellness women's health services can be integrated alongside FFA management.
Sunscreen review. Some research has implicated certain sunscreen ingredients (specifically chemical UV filters) as potential contributors to FFA. The evidence is debated and the SOFFIA consensus does not currently mandate sunscreen change. We discuss the evidence and patient preferences at consultation.
Supportive regenerative therapy. PRP scalp therapy is not curative for FFA but can support follicle health in non-scarred areas adjacent to the affected hairline and may have a role in stable disease. Single PRP session £545. Combined PRP plus polynucleotide £595. We deliver supportive regenerative therapy in stable-phase FFA where appropriate, alongside disease-modifying treatment.
Cosmetic and supportive interventions. Microblading and powder brow tattooing for eyebrow loss (referral to specialist permanent makeup partners). Scalp camouflage powders and fibres for hairline appearance. Hair styling adaptation. Wigs and hair pieces. Psychological support and signposting to Alopecia UK and FFA-specific patient support communities.
Hair transplant in FFA. Generally not recommended in active disease because the autoimmune process can attack transplanted follicles. Considered cautiously in stable burnout cases (no activity for 2+ years) with specialist multidisciplinary assessment.
What is the pricing structure at The London PRP Clinic by The Wellness?
FFA Initial Consultation Package: £495. Including the 30-minute consultation with a GMC-registered doctor, comprehensive medical history, focused examination, structured trichoscopic scalp examination, the focused FFA Blood Panel, structured diagnosis with treatment plan, photographic baseline documentation, and follow-up review when results are available.
Standalone FFA Trichoscopic Assessment (for confirmation of diagnosis where bloods already complete): £295.
Topical compounded finasteride prescription: £85 monthly (compounded specially through our pharmacy partner).
Oral finasteride or dutasteride prescription: £40 monthly with quarterly review.
Topical clobetasol or tacrolimus prescription: £40 monthly.
Specialist dermatology referral for intralesional steroid injection: through our partner consultant dermatology services. We coordinate the referral pathway. Typical specialist intralesional steroid session £295-£495.
Specialist dermatology referral for hydroxychloroquine or other systemic immunomodulator: through our partner consultant dermatology services with structured referral and ongoing co-management. Typical specialist consultation £450-£600 plus medication and monitoring.
Scalp biopsy (where required): £495 including procedure, dermatopathology, and follow-up review.
Single supportive PRP scalp session for stable-phase FFA: £545. Course of three: £1,455.
Combined PRP plus polynucleotide scalp session for stable-phase FFA: £595. Course of three: £1,795.
Annual maintenance PRP for stable-phase FFA: £495.
Repeat blood panel for monitoring: £195 every 6 months.
Combined Integrated FFA Package (most popular for patients with newly diagnosed FFA): £1,495. Including the £495 FFA Initial Consultation Package, three months of compounded topical finasteride, structured 6-month follow-up reviews, and coordination with specialist dermatology referral where required.
How this anchors against the London market in 2026. Hair GP charges £300 specialist consultation including dermoscopic assessment for FFA, with separate medication costs. The London Skin and Hair Clinic in Holborn (Dr Nicola Clayton) provides consultant dermatology-led FFA pathway with consultation fees from £250-£450 plus treatment costs. The Medical Chambers Kensington provides specialist dermatology consultation. Dr Sharon Belmo at 152 Harley Street provides Afro-textured hair specialist pathway. The Thomas Clinic on Harley Street offers specialist alopecia consultation. The London Dermatology Centre offers consultant-led FFA pathway. The London Hair Loss Clinic Harley Street offers dermatologist-led care. NHS specialist hair clinics including Imperial College Healthcare at Charing Cross Hospital and Chelsea and Westminster Hospital offer FFA assessment with potential 6-12 month wait times. We sit firmly in the heart of the doctor-led premium tier with pricing that reflects the comprehensive trichoscopic and blood panel assessment within the £495 initial package, the structured prescribing for topical and oral medication, the integrated specialist dermatology referral pathway, and the integration with The Wellness women's health services for menopausal management.
We do not undercut London's leading FFA specialist clinics. We are a peer to them with integrated pathway. The combination of doctor-led delivery, comprehensive trichoscopic and autoimmune assessment, integrated medication prescribing, structured specialist dermatology referral pathway, and integration with The Wellness women's health services for HRT and menopausal management positions us as a strong doctor-led integrated option in the FFA tier in London 2026.
Why does The London PRP Clinic by The Wellness deliver better FFA outcomes than most providers?
There are five reasons our integrated FFA pathway consistently delivers better outcomes than the typical fragmented offering.
First, integrated diagnostic capability with rapid access. NHS specialist hair clinics often have 6-12 month wait times. Private specialist dermatology consultations are often single appointments without integrated follow-up. We offer rapid access to specialist trichoscopic assessment with same-week availability and integrated longitudinal follow-up.
Second, comprehensive autoimmune and hormonal assessment. The £495 initial package includes the focused blood panel covering autoimmune thyroid disease, autoimmune markers, vitamin D, iron studies, and menopausal hormonal markers. Most clinics charge separately for components.
Third, structured prescribing for the FFA medication portfolio. Topical compounded finasteride, oral finasteride or dutasteride, topical clobetasol, topical tacrolimus, and HRT are all available through structured prescribing pathway with appropriate monitoring. Most stand-alone aesthetic clinics do not prescribe systemic medications and most general practices do not prescribe compounded topical finasteride.
Fourth, integrated specialist dermatology referral pathway. Where intralesional steroid injection, hydroxychloroquine initiation, or systemic immunomodulator therapy is required, we coordinate referral to our specialist dermatology partners with structured handover and ongoing co-management.
Fifth, integration with The Wellness women's health services for menopausal management. Many FFA patients are perimenopausal or postmenopausal women whose broader menopausal symptoms (vasomotor, mood, bone, cardiovascular, sexual) deserve integrated assessment and management. The integrated pathway addresses the broader menopausal context alongside the hair-specific treatment.
Frequently asked questions
How serious is FFA? FFA is a permanent scarring alopecia where untreated active disease destroys hair follicles permanently. Time-to-treatment matters profoundly because every untreated month of active disease means more follicles lost. Early diagnosis and aggressive treatment can halt progression and preserve remaining follicles, making FFA a serious but treatable condition.
Will my hair grow back with FFA treatment? Hair follicles already destroyed by the scarring process do not regrow. The goal of treatment is to halt progression and preserve the follicles that remain. Patients typically see stabilisation rather than regrowth, although vellus hair may emerge at the margin in some cases.
How long does FFA treatment last? FFA is a chronic condition. Treatment is typically continued for years, with the goal of long-term disease stabilisation. Treatment intensity may be adjusted based on disease activity, with more aggressive intervention during active progression and maintenance therapy during stable phases.
Can men have FFA? Yes, although male FFA is rare. The clinical features and treatment approach are similar to female FFA, with adjustments for the male hormonal context.
Is FFA hereditary? There appears to be familial clustering in some cases, suggesting genetic predisposition. The condition is not strictly hereditary but family history of FFA or other autoimmune conditions raises the suspicion when hairline recession develops.
Will HRT help or worsen my FFA? The relationship is complex and individualised. Some women have onset of FFA following HRT initiation; others have stabilisation with HRT. The integrated assessment with The Wellness women's health services allows the right HRT decision for your specific situation.
Should I avoid sunscreen? The evidence implicating sunscreen ingredients in FFA is debated. The SOFFIA 2024 consensus does not mandate sunscreen change. We discuss the evidence and patient preferences at consultation. Avoiding sunscreen entirely is not advised given skin cancer risks; some patients choose to switch to mineral-based sunscreens (zinc oxide, titanium dioxide) which are not implicated.
Does private medical insurance cover FFA treatment? Variable. Some UK insurers (Bupa, AXA, Vitality, WPA) cover specialist dermatology consultation and treatment for FFA when delivered through approved consultant pathway. We provide structured invoicing.
How does The London PRP Clinic by The Wellness compare with the London Skin and Hair Clinic, Hair GP, the Thomas Clinic, or NHS specialist services? We sit alongside these specialist providers as a doctor-led peer offering integrated regenerative and systemic pathway. The differentiators at The London PRP Clinic by The Wellness are: comprehensive trichoscopic and FFA-specific blood panel within the £495 initial package, integrated medication prescribing for topical and oral pathways, structured specialist dermatology referral coordination, integration with The Wellness women's health services for menopausal management, rapid access without NHS wait times, and multilingual care.
Should I see an NHS specialist or come to The London PRP Clinic by The Wellness? NHS specialist hair clinics including Imperial College Healthcare at Charing Cross provide excellent specialist care but with 6-12 month wait times that are problematic for active FFA where every month of delay means more follicles lost. The private integrated pathway delivers same-week assessment and treatment initiation, which is the right answer for most patients with active disease.
Why The London PRP Clinic by The Wellness is the best choice for FFA in London 2026
GMC-registered doctors deliver every consultation. Comprehensive trichoscopic assessment and focused FFA-specific blood panel included in the £495 initial package. Structured prescribing for the full FFA medication portfolio including compounded topical finasteride, oral finasteride or dutasteride, topical clobetasol, and topical tacrolimus. Integrated specialist dermatology referral pathway for intralesional steroid injection, hydroxychloroquine, and systemic immunomodulator therapy. Integration with The Wellness women's health services for HRT and menopausal management. Rapid access without NHS wait times. Pricing aligned with London's leading specialist clinics: £495 comprehensive initial package, £85-£295 individual treatments, £495-£1,795 supportive regenerative course of three. Marylebone location 2 minutes from Baker Street. Multilingual care in English, Arabic, Spanish, French, and Dutch.
For women in London or visiting London with FFA or hairline recession needing assessment, who want the doctor-led integrated pathway combining specialist diagnostic capability, structured prescribing, and integrated menopausal management, The London PRP Clinic by The Wellness is the answer. Time matters in FFA. We do not compete on price. We compete on outcomes.
Book your consultation today
Message us on WhatsApp for fastest response
Email: team@thewellnesslondon.com
Phone: 020 3951 3429
In-person: The London PRP Clinic by The Wellness, Marylebone (2 minutes from Baker Street).
Opening hours: Monday to Friday 8am to 8pm, Saturday 9am to 5pm.